- Home
- TLSI vs USAS Comparison
TLSI vs USAS Comparison
Compare TLSI & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- USAS
- Stock Information
- Founded
- TLSI 2010
- USAS 1998
- Country
- TLSI United States
- USAS Canada
- Employees
- TLSI N/A
- USAS N/A
- Industry
- TLSI Medical Specialities
- USAS Metal Mining
- Sector
- TLSI Health Care
- USAS Basic Materials
- Exchange
- TLSI Nasdaq
- USAS Nasdaq
- Market Cap
- TLSI 124.9M
- USAS 122.4M
- IPO Year
- TLSI N/A
- USAS N/A
- Fundamental
- Price
- TLSI $3.95
- USAS $0.38
- Analyst Decision
- TLSI Strong Buy
- USAS Strong Buy
- Analyst Count
- TLSI 6
- USAS 1
- Target Price
- TLSI $11.75
- USAS $0.80
- AVG Volume (30 Days)
- TLSI 52.7K
- USAS 695.5K
- Earning Date
- TLSI 11-14-2024
- USAS 11-07-2024
- Dividend Yield
- TLSI N/A
- USAS N/A
- EPS Growth
- TLSI N/A
- USAS N/A
- EPS
- TLSI N/A
- USAS N/A
- Revenue
- TLSI $26,891,000.00
- USAS $97,123,000.00
- Revenue This Year
- TLSI $60.97
- USAS $21.84
- Revenue Next Year
- TLSI $53.69
- USAS $46.00
- P/E Ratio
- TLSI N/A
- USAS N/A
- Revenue Growth
- TLSI 67.90
- USAS 14.33
- 52 Week Low
- TLSI $3.50
- USAS $0.20
- 52 Week High
- TLSI $10.42
- USAS $0.54
- Technical
- Relative Strength Index (RSI)
- TLSI 46.18
- USAS 44.85
- Support Level
- TLSI $3.76
- USAS $0.37
- Resistance Level
- TLSI $4.17
- USAS $0.44
- Average True Range (ATR)
- TLSI 0.35
- USAS 0.03
- MACD
- TLSI -0.04
- USAS -0.00
- Stochastic Oscillator
- TLSI 33.66
- USAS 14.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.